Validation of a Prognostic Assay for Embryo Transfer Outcome

胚胎移植结果的预后测定的验证

• 批准号: nhmrc : GNT1159714
• 负责人: Dr Tracey Edgell
• 金额: $ 34.7万
• 依托单位: Monash University
• 依托单位国家: 澳大利亚
• 项目类别: Development Grants
• 财政年份: 2019
• 资助国家: 澳大利亚
• 起止时间: 2019-01-01 至 无数据
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/validation-prognostic-assay-transfer-outcome/1349305
• 关键词: Validation; Prognostic; Assay; Embryo; Transfer

Contrary to popular belief many women using in vitro fertilization (IVF) will remain childless. High costs of IVF and limited access to financial assistance has generated a socio-economic divide in accessing treatment. We will collect blood from women at three sites and measure six proteins in the blood to predict if the mother’s body is ready to accept and nurture an embryo, establishing pregnancy and continuing to a live birth. Successful outcome would reduce the failure rate.

与流行的看法相反，许多使用体外受精（IVF）的妇女将保持无子女。试管婴儿的高成本和获得财政援助的机会有限，在获得治疗方面产生了社会经济鸿沟。我们将在三个地点收集女性的血液，并测量血液中的六种蛋白质，以预测母亲的身体是否准备好接受和培育胚胎，建立怀孕并继续活产。成功的结果将降低失败率。